Like the flu vaccine every year, the FDA could move quickly on a variant-targeted Covid vaccine

In the same way that the FDA signs off on flu vaccines every year without requiring large clinical trials to measure their efficacy, the FDA may employ a similar strategy in authorizing variant-focused versions of the mRNA vaccines.